Aug 04, 2026
446:411
For every 411 shares held, investors received 446. The price per share adjusted from $8280.00 to $7630.22.
The split itself did not change the total investment value.
HLB PHARMACEUTICAL CO., LTD. (KRX:047920) operates in the Pharmaceuticals: major industry.
HLB PHARMACEUTICAL CO., LTD. company overviewHLB PHARMACEUTICAL CO., LTD.'s most recent stock split was on August 4, 2026. It was a 446-for-411 forward split, so shareholders received 446 shares for every 411 they held.
HLB PHARMACEUTICAL CO., LTD. (KRX:047920) has split its stock 2 times: a 3-for-2 split on April 12, 2016 and a 446-for-411 split on August 4, 2026.
HLB PHARMACEUTICAL CO., LTD. has split its stock 2 times. This history records 2 forward splits between April 12, 2016 and August 4, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In HLB PHARMACEUTICAL CO., LTD.'s 446-for-411 split on August 4, 2026, every 411 shares became 446 shares.
HLB PHARMACEUTICAL CO., LTD. has not announced a new split in our records. Its most recent split was on August 4, 2026, less than a year ago. Companies announce splits in advance, and any new KRX:047920 split will appear on this page.
Already premium?